Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Capricor Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 31 | 30 | −1 |
| Shares | 2.74M | 2.43M | −305.3K (−11.1%) |
| Value | $10.6M | $10.3M | −$299.6K (−2.8%) |
New holders (6)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commonwealth Equity Services, LLC | 30,000 | $126.0K | 0.00% |
| Virtu Financial LLC | 16,895 | $71.0K | 0.01% |
| Charles Schwab Investment Management Inc | 13,479 | $56.9K | 0.00% |
| UBS Group AG | 4,439 | $18.7K | 0.00% |
| Royal Bank of Canada | 1,400 | $6.00K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 700 | $3.00K | 0.00% |
Sold out (7)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 52,728 | $204.0K |
| Cubist Systematic Strategies, LLC | 29,387 | $113.4K |
| Marshall Wace, LLP | 28,359 | $109.5K |
| HighTower Advisors, LLC | 19,885 | $76.0K |
| Jump Financial, LLC | 14,595 | $56.3K |
| Simplex Trading, LLC | 13,943 | $53.0K |
| Federated Hermes, Inc. | 111 | $428 |